New incident report
Incident Report Number: 2019-6278
Registrant Reference Number: 2019-US-016460
Registrant Name (Full Legal Name no abbreviations): The Hartz Mountain Corporation
Address: 400 Plaza Drive
City: Secaucus
Prov / State: New Jersey
Country: USA
Postal Code: 07094-3688
Domestic Animal
Country: UNITED STATES
Prov / State: MAINE
PMRA Registration No. PMRA Submission No. EPA Registration No. 2596-126
Product Name: Hartz UltraGuard Flea and Tick Spray for Cats
Other (specify)
SprayYes
Unknown
Site: Animal / Usage sur un animal domestique
Unknown
Animal's Owner
Cat / Chat
Domestic Longhair
1
Female
5
5
lbs
Skin
>3 days <=1 wk / >3 jours <=1 sem
>3 days <=1 wk / >3 jours <=1 sem
System
Persisted until death
No
No
Died
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
On 10-Jul-2019 the pet owner applied Hartz UltraGuard Flea and Tick Spray for Cats (Tetrachlorvinphos) to each of her four cats for the first time to treat a flea infestation. On 14-Jul-2019 one cat rolled in some dirt in the basement of the home. The owner reported she did not know of anything in the basement that would be toxic. The owner bathed the cat using liquid dish soap within a few hours. The cat vocalized during the bath, which was not unusual, but sounded different than normal. While drying the cat with a towel, it became limp and then died within an hour. The owner attempted CPR but was unsuccessful. No necropsy was performed and the cat was buried. The three other cats in the home remained asymptomatic and were not bathed.
Death
Assessment: This product has a wide margin of safety in cats when used per label directions. Even if ingested from the fur following use, only mild oral irritation or gastrointestinal upset resulting in drooling or vomiting would be expected. Signs did not occur in this case until four days after product use and after the cat rolled in dirt in the basement. It is unknown what else the cat may have been exposed to in the basement. Also, three other cats in the home remained asymptomatic following product use, adding to the unlikeliness that the product was the cause of the catżżżżżżs signs in this case. The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.